Cargando…

Pituitary-Directed Therapies for Cushing’s Disease

Cushing’s disease (CD) is caused by a pituitary corticotroph neuroendocrine tumor inducing uncontrolled hypercortisolism. Transsphenoidal surgery is the first-line treatment in most cases. Nonetheless, some patients will not achieve cure even in expert hands, others may not be surgical candidates an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Langlois, Fabienne, Chu, Jennifer, Fleseriu, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5938400/ https://www.ncbi.nlm.nih.gov/pubmed/29765354 http://dx.doi.org/10.3389/fendo.2018.00164

Ejemplares similares

Hypercoagulability and Risk of Venous Thromboembolic Events in Endogenous Cushing's Syndrome: A Systematic Meta-Analysis
por: Wagner, Jeffrey, et al.
Publicado: (2019)

Recent Progress in the Medical Therapy of Pituitary Tumors
por: Langlois, Fabienne, et al.
Publicado: (2017)

Hypercortisolemia Recurrence in Cushing's Disease; a Diagnostic Challenge
por: Hinojosa-Amaya, José Miguel, et al.
Publicado: (2019)

Hypophysitis, the Growing Spectrum of a Rare Pituitary Disease
por: Langlois, Fabienne, et al.
Publicado: (2021)

Medical Therapy with Pasireotide in Recurrent Cushing’s Disease: Experience of Patients Treated for At Least 1 Year at a Single Center
por: Yedinak, Chris G., et al.
Publicado: (2017)

Pituitary Disorders and COVID-19, Reimagining Care: The Pandemic A Year and Counting
por: Fleseriu, Maria
Publicado: (2021)

The expression of glucocorticoid and mineralocorticoid receptors in pituitary tumors causing Cushing’s disease and silent corticotroph tumors
por: Kober, Paulina, et al.
Publicado: (2023)

Response to Letter to the Editor From Asa and Mete: “Hypophysitis, the Growing Spectrum of a Rare Pituitary Disease”
por: Langlois, Fabienne, et al.
Publicado: (2022)

Cushing’s Syndrome and Hypothalamic–Pituitary–Adrenal Axis Hyperactivity in Chronic Central Serous Chorioretinopathy
por: van Haalen, Femke M., et al.
Publicado: (2018)

Safety and Efficacy of Subcutaneous Pasireotide in Patients With Cushing's Disease: Results From an Open-Label, Multicenter, Single-Arm, Multinational, Expanded-Access Study
por: Fleseriu, Maria, et al.
Publicado: (2019)

Long-term efficacy and safety of subcutaneous pasireotide alone or in combination with cabergoline in Cushing’s disease
por: Feelders, Richard A., et al.
Publicado: (2023)

Distinct serum steroid profiles between adrenal Cushing syndrome and Cushing disease
por: Gao, Chang, et al.
Publicado: (2023)

Levoketoconazole in the Treatment of Patients With Cushing’s Syndrome and Diabetes Mellitus: Results From the SONICS Phase 3 Study
por: Pivonello, Rosario, et al.
Publicado: (2021)

Recent advances in the medical treatment of Cushing’s disease
por: Fleseriu, Maria
Publicado: (2014)

New avenues in the medical treatment of Cushing’s disease: corticotroph tumor targeted therapy
por: Fleseriu, Maria, et al.
Publicado: (2013)

THU214 Exploratory Study Of The Association Of Genetic Factors With Recovery Of Hypothalamic-Pituitary-Adrenal Axis In Cushing Disease
por: Nguyen, Matthew H, et al.
Publicado: (2023)

Diabetes Mellitus Secondary to Cushing’s Disease
por: Barbot, Mattia, et al.
Publicado: (2018)

Quality of Life in Patients With Cushing's Disease
por: Santos, Alicia, et al.
Publicado: (2019)

Cushing’s Disease Management: Glimpse Into 2051
por: Dalan, Rinkoo, et al.
Publicado: (2022)

Medical management of Cushing’s disease: what is the future?
por: Fleseriu, Maria, et al.
Publicado: (2012)

Neuropsychiatric disorders in Cushing's syndrome
por: Pivonello, Rosario, et al.
Publicado: (2015)

Individualized medical treatment options in Cushing disease
por: Gilis-Januszewska, Aleksandra, et al.
Publicado: (2022)

Clinical, Biological, Radiological Pathological and Immediate Post-Operative Remission of Sparsely and Densely Granulated Corticotroph Pituitary Tumors: A Retrospective Study of a Cohort of 277 Patients With Cushing’s Disease
por: Rak, Beata, et al.
Publicado: (2021)

Pituitary oncocytoma presenting as Cushing's disease
por: Garg, M.K., et al.
Publicado: (2013)

Depression and Impulsivity Self-Assessment Tools to Identify Dopamine Agonist Side Effects in Patients With Pituitary Adenomas
por: Hinojosa-Amaya, José Miguel, et al.
Publicado: (2020)

Clinical Study and Systematic Review of Pituitary Microadenomas vs. Macroadenomas in Cushing’s Disease: Does Size Matter?
por: Akirov, Amit, et al.
Publicado: (2022)

Update on medical treatment for Cushing’s disease
por: Cuevas-Ramos, Daniel, et al.
Publicado: (2016)

Crossover of the Hypothalamic Pituitary–Adrenal/Interrenal, –Thyroid, and –Gonadal Axes in Testicular Development
por: Castañeda Cortés, Diana C., et al.
Publicado: (2014)

Individualized acromegaly treatment: Is stereotactic radiation therapy changing the paradigm?
por: Liu, Winnie, et al.
Publicado: (2022)

Medical treatment of Cushing’s disease with concurrent diabetes mellitus
por: Mehlich, Anna, et al.
Publicado: (2023)

Perioperative Management of a Patient With Cushing Disease
por: Varlamov, Elena V, et al.
Publicado: (2022)

A New Clinical Model to Estimate the Pre-Test Probability of Cushing’s Syndrome: The Cushing Score
por: Parasiliti-Caprino, Mirko, et al.
Publicado: (2021)

Evaluation of ketoconazole as a treatment for Cushing’s disease in a retrospective cohort
por: Viecceli, Camila, et al.
Publicado: (2022)

Medical Treatment of Cushing's Disease: An Overview of the Current and Recent Clinical Trials
por: Pivonello, Rosario, et al.
Publicado: (2020)

Aggressive Cushing’s Disease: Molecular Pathology and Its Therapeutic Approach
por: Yamamoto, Masaaki, et al.
Publicado: (2021)

Editorial: Current Clinical and Pre-Clinical Progress in Cushing’s Disease
por: Stalla, Günter Karl, et al.
Publicado: (2020)

The patient’s sex determines the hemodynamic profile in patients with Cushing disease
por: Jurek, Agnieszka, et al.
Publicado: (2023)

Pituitary tumor centers of excellence for Cushing’s disease
por: Couselo, Marcos, et al.
Publicado: (2022)

Double Pituitary Adenomas in Patients With Cushing’s Disease
por: Voznyak, Oleksandr, et al.
Publicado: (2023)

Updates on the role of adrenal steroidogenesis inhibitors in Cushing’s syndrome: a focus on novel therapies
por: Fleseriu, Maria, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_irip7cgb04a9jeequ3b0b2ocod